Literature DB >> 23345080

A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.

Alejandro López-Jiménez1, Nicole A R Walter, Elena Giné, Ángel Santos, Victor Echeverry-Alzate, Kora-Mareen Bühler, Pedro Olmos, Stéphanie Giezendanner, Rosario Moratalla, Lluis Montoliu, Kari J Buck, Jose Antonio López-Moreno.   

Abstract

α-Synuclein (α-syn) protein and endocannabinoid CB1 receptors are primarily located in presynaptic terminals. An association between α-syn and CB1 receptors has recently been established in Parkinson's disease, but it is completely unknown whether there is an association between these two proteins in alcohol addiction. Therefore, we aimed to examine the α-syn mRNA transcript and protein expression levels in the prefrontal cortex, striatum, amygdala and hippocampus. These brain regions are the most frequently implicated in alcohol and other drug addiction. In these studies, we used C57BL/6 mice carrying a spontaneous deletion of the α-syn gene (C57BL/6(Snca-/-) ) and their respective controls (C57BL/6(Snca) (+/) (+) ). These animals were monitored for spontaneous alcohol consumption (3-10%) and their response to a hypnotic-sedative dose of alcohol (3 g kg(-1) ) was also assessed. Compared with the C57BL/6(Snca+/+) mice, we found that the C57BL/6(Snca-/-) mice exhibited a higher expression level of the CB1 mRNA transcript and CB1 receptor in the hippocampus and amygdala. Furthermore, C57BL/6(Snca-/-) mice showed an increase in alcohol consumption when offered a 10% alcohol solution. There was no significant difference in sleep time after the injection of 3 g/kg alcohol. These results are the first to reveal an association between α-syn and the CB1 receptor in the brain regions that are most frequently implicated in alcohol and other drug addictions.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345080      PMCID: PMC3931467          DOI: 10.1002/syn.21639

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  56 in total

1.  The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.

Authors:  José Antonio López-Moreno; Gustavo González-Cuevas; Miguel Navarro
Journal:  Neurobiol Dis       Date:  2006-10-24       Impact factor: 5.996

2.  Association of alcohol craving with alpha-synuclein (SNCA).

Authors:  Tatiana Foroud; Leah Flury Wetherill; Tiebing Liang; Danielle M Dick; Victor Hesselbrock; John Kramer; John Nurnberger; Marc Schuckit; Lucinda Carr; Bernice Porjesz; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

3.  Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American Indian populations.

Authors:  Jordi Clarimon; Rebecca R Gray; Lindsey N Williams; Mary-Anne Enoch; Robert W Robin; Bernard Albaugh; Andrew Singleton; David Goldman; Connie J Mulligan
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

4.  Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.

Authors:  S Ares-Santos; N Granado; I Oliva; E O'Shea; E D Martin; M I Colado; R Moratalla
Journal:  Neurobiol Dis       Date:  2011-11-13       Impact factor: 5.996

5.  Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence.

Authors:  D Bönsch; T Lederer; U Reulbach; T Hothorn; J Kornhuber; S Bleich
Journal:  Hum Mol Genet       Date:  2005-02-24       Impact factor: 6.150

Review 6.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

Review 7.  Modulation of alpha-synuclein aggregation by dopamine: a review.

Authors:  Su Ling Leong; Roberto Cappai; Kevin Jeffrey Barnham; Chi Le Lan Pham
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

8.  A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Authors:  Alexander Kurz; Kay L Double; Isabel Lastres-Becker; Alessandro Tozzi; Michela Tantucci; Vanessa Bockhart; Michael Bonin; Moisés García-Arencibia; Silke Nuber; Falk Schlaudraff; Birgit Liss; Javier Fernández-Ruiz; Manfred Gerlach; Ullrich Wüllner; Hartmut Lüddens; Paolo Calabresi; Georg Auburger; Suzana Gispert
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

9.  Spatial learning is unimpaired in mice containing a deletion of the alpha-synuclein locus.

Authors:  Philip E Chen; Christian G Specht; Richard G M Morris; Ralf Schoepfer
Journal:  Eur J Neurosci       Date:  2002-07       Impact factor: 3.386

10.  Deletion of alpha-synuclein decreases impulsivity in mice.

Authors:  Y Peña-Oliver; V L Buchman; J W Dalley; T W Robbins; G Schumann; T L Ripley; S L King; D N Stephens
Journal:  Genes Brain Behav       Date:  2011-12-29       Impact factor: 3.449

View more
  4 in total

Review 1.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

2.  The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain.

Authors:  Moritz Möller; Christine V Möser; Ulrike Weiß; Ellen Niederberger
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

3.  Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain.

Authors:  Rachel Kelly; Alexis-Pierre Bemelmans; Charlène Joséphine; Emmanuel Brouillet; Declan P McKernan; Eilís Dowd
Journal:  Molecules       Date:  2022-01-14       Impact factor: 4.411

Review 4.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.